Epinoma

Epinoma is a biotechnology startup founded in 2020 that is revolutionizing the field with its innovative approach. The company's slogan, "We engineer proteins that control the operating system of biology," encapsulates its core mission. Epinoma aims to make the world a healthier place by leveraging protein engineering to enhance the performance of blood test developers, targeting a substantial $50 billion market. The startup's groundbreaking technology holds the potential to not only improve existing products but also pave the way for a new generation of epigenetic medicines, offering enhanced safety and efficacy for patients.

With its focus on epigenetics, Epinoma is utilizing a protein platform to manipulate biological signals, with the aim of early disease detection and intervention. By targeting structural modifications that impact the human genome, the company seeks to contribute to proactive healthcare and disease management.

The latest milestone for Epinoma came with a Pre Seed Round investment on 21 October 2021, with SeedtoB Capital as the investor. This significant backing underscores the potential that investors see in Epinoma's innovative approach to biotechnology. With its headquarters in the United States, the startup is well-positioned to drive meaningful change in the healthcare industry and beyond.